19 Dec 2024 10:39
PT Murni Sadar Tbk (MTMH), the operator of Murni Teguh Hospitals, has acquired 80% of the shares of PT Global Genetika Indonesia (GGI) for IDR 3.56 billion to enhance its medical laboratory services.
01 Nov 2024 14:58
PT Prodia Widyahusada Tbk (PRDA), the company that oversees the Prodia laboratory network, is still experiencing a downward trend in net profit until September 2024.
28 Jun 2024 12:51
PT Prodia Widyahusada Tbk (PRDA) takes an extra measure to secure supply chain of in vitro diagnostic (IVD) test tools by acquiring 39% of its affiliate, PT Prodia Diagnostic Line (Proline).
18 Apr 2024 16:06
PT Prodia Widyahusada Tbk (PRDA) has prepared moderate amount of capital expenditure (capex) in 2024, worth a maximum of IDR 250 billion.
18 Apr 2024 11:14
PT Prodia Widyahusada Tbk (PRDA), a company managing Prodia laboratory network, has allocated IDR 155.6 billion to be distributed to its shareholders as cash dividend.
14 Mar 2024 14:02
PT Diagnos Laboratorium Utama Tbk (DGNS) will acquire 97.97% of the shares of Asa Ren Pte. Ltd, an AI-based DNA data company registered in Singapore, with a transaction value estimated at IDR 357.89 billion.
05 Mar 2024 11:35
PT Diagnos Laboratorium Utama Tbk (DGNS), a medical laboratory service provider under PT Bundamedik Tbk (BMHS), booked a loss of IDR 13.65 billion in 2023.
16 Mar 2023 07:03
The profit of PT Prodia Widyahusada Tbk (PRDA) was seen slipping off 40.37% to IDR 371.62 billion in December 2022, compared to IDR 623.23 billion seen in December 2021.
